Cargando...

Precision monitoring takes the stage

In this issue of Blood, Assouline et al report the clinical activity of the oral histone deacetylase inhibitor, panobinostat, in 40 patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) not preselected on the basis of molecular subtype as well as transformed lymphomas.(1) The au...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Blood
Autor principal: Roschewski, Mark
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Hematology 2016
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4946197/
https://ncbi.nlm.nih.gov/pubmed/27418622
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-05-717520
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!